Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Standard Biotools (LAB) over the last 16 years, with Q3 2025 value amounting to $1.8 million.

  • Standard Biotools' Change in Inventory fell 1542.43% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 million, marking a year-over-year decrease of 6788.0%. This contributed to the annual value of $9.9 million for FY2024, which is 10103.79% up from last year.
  • As of Q3 2025, Standard Biotools' Change in Inventory stood at $1.8 million, which was down 1542.43% from $4.7 million recorded in Q2 2025.
  • Standard Biotools' 5-year Change in Inventory high stood at $6.4 million for Q2 2024, and its period low was -$5.0 million during Q4 2024.
  • In the last 5 years, Standard Biotools' Change in Inventory had a median value of $1.8 million in 2025 and averaged $2.0 million.
  • Per our database at Business Quant, Standard Biotools' Change in Inventory surged by 612727.27% in 2022 and then plummeted by 40380.43% in 2024.
  • Quarter analysis of 5 years shows Standard Biotools' Change in Inventory stood at -$2.7 million in 2021, then soared by 124.58% to $660000.0 in 2022, then soared by 150.91% to $1.7 million in 2023, then plummeted by 403.8% to -$5.0 million in 2024, then surged by 135.86% to $1.8 million in 2025.
  • Its last three reported values are $1.8 million in Q3 2025, $4.7 million for Q2 2025, and $3.8 million during Q1 2025.